
Moxipray-CV 625 Tablet
Marketer
Medivaxia Pharma
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Moxipray-CV 625 Tablet
Augmentin-equivalent 625mg tablets combat bacterial infections by bolstering your body's defenses. This medication effectively treats infections affecting the lungs (like pneumonia), ears, sinuses, urinary tract, skin, and soft tissues. It's ineffective against viral illnesses such as the common cold. For optimal absorption and minimized stomach discomfort, consume this medication with food. Adhere strictly to your physician's prescribed dosage schedule, maintaining consistent intervals between doses. Regular, timed administration enhances compliance. Treatment duration depends on your specific condition; always complete the full course as directed. Premature cessation may allow surviving bacteria to cause relapse or intensified infection. Common side effects may include nausea, diarrhea, vomiting, oral or genital yeast infections, skin rashes, and vaginal inflammation. While generally mild, persistent or bothersome effects warrant medical attention. Prior to commencing treatment, disclose any antibiotic allergies, kidney or liver issues, and all other medications you are currently using, as interactions are possible. This antibiotic is generally deemed safe for pregnant and breastfeeding individuals under medical supervision.
Uses of Moxipray-CV 625 Tablet
Managing bacterial infections
Major Benefits of Moxipray-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Moxipray-CV 625 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Moxipray-CV 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Moxipray-CV 625 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Moxipray-CV 625 Tablet whole; do not chew, crush, or fracture it. Administer this medication with food.
How Moxipray-CV 625 Tablet works:
Moxipray-CV 625 tablets contain amoxicillin, an antibiotic, and clavulanic acid, a beta-lactamase inhibitor. Amoxicillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Clavulanic acid counteracts bacterial resistance mechanisms, thereby boosting amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Moxipray-CV 625 Tablet presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Using Moxipray-CV 625 Tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Moxipray-CV 625 Tablet is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Moxipray-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Moxipray-CV 625 Tablets; dosage modification may be necessary. Consult your physician for guidance. This medication is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Moxipray-CV 625 Tablets; dosage modification may be necessary. Physician consultation is advised. Routine liver function tests are recommended during treatment.
What if you forget to take Moxipray-CV 625 Tablet :
Should you forget a Moxipray-CV 625 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Moxipray-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
